How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring

Acute myeloid leukemia (AML) carrying inv(16)/t(16;16), resulting in fusion transcript CBFB-MYH11, belongs to the favorable-risk category. However, even if most patients obtain morphological complete remission after induction, approximately 30% of cases eventually relapse. While well-established cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Talami, Annalisa, Bettelli, Francesca, Pioli, Valeria, Giusti, Davide, Gilioli, Andrea, Colasante, Corrado, Galassi, Laura, Giubbolini, Rachele, Catellani, Hillary, Donatelli, Francesca, Maffei, Rossana, Martinelli, Silvia, Barozzi, Patrizia, Potenza, Leonardo, Marasca, Roberto, Trenti, Tommaso, Tagliafico, Enrico, Comoli, Patrizia, Luppi, Mario, Forghieri, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391269/
https://www.ncbi.nlm.nih.gov/pubmed/34440157
http://dx.doi.org/10.3390/biomedicines9080953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391269/
https://www.ncbi.nlm.nih.gov/pubmed/34440157
http://dx.doi.org/10.3390/biomedicines9080953

Ejemplares similares